Articles tagged with Death Receptors
Researchers found that SARS-CoV-2 spike protein interrupts p53-MDM2 interaction but does not bind with p53 protein in cancer cells. The study also shows that SARS-CoV-2 spike suppresses p53-dependent gene activation, leading to increased cell viability after chemotherapy exposure.
Researchers discover presumed SARS-CoV-2 viral particles in the human retina of COVID-19 patients. The finding suggests a possible link between the virus and ocular clinical manifestations, highlighting the need for further investigation into the virus's effects on the eyes.
A systematic review and meta-analysis found individuals with preexisting mood disorders are at a higher risk of COVID-19 hospitalization and death. This suggests that those with preexisting mood disorders should be categorized as an at-risk group on the basis of a preexisting condition.
A team led by Dr. Sjoerd van Wijk is exploring M1-deubiquitinating enzymes and their interactions with death receptors to better comprehend programmed cell death regulation. This research may lead to insights into human diseases, such as cancer development and bacterial invasion.
The study found that increased cell death is linked to elevated levels of three death receptor family members, TNFR-1, TRAILR-2, and Fas. High blood sugar and fats subject blood vessels and insulin-producing cells to stress, triggering a cell suicide program.
A new tumor marker has been identified for brain tumor resistance, allowing for targeted therapy approaches. The discovery of a
Death receptors, which eliminate unwanted cells, may also be used to strengthen cells against illnesses. Researchers can develop new therapeutics that target these receptors to treat various diseases.